AbbVie (ABBV) FCF Margin (2012 - 2026)
AbbVie (ABBV) reported FCF Margin of 23.76% for Q1 2026, up 1326.0% year-over-year from 1.67% in Q1 2025, and down 19.25% quarter-over-quarter from 29.42% in Q4 2025.
AbbVie (ABBV) FCF Margin (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has 15 years of FCF Margin data on file, last reported at 23.76% in Q1 2026.
- FCF Margin for Q1 2026 came in at 23.76%, up 1326.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 31.81% (up 499.0% YoY), and the FY2025 annual result was 29.13%, down 252.0% from the prior year.
- FCF Margin eased to 23.76% in Q1 2026 per ABBV's latest filing, from 29.42% in the prior quarter.
- Over five years, FCF Margin peaked at 52.81% in Q3 2023 and troughed at 10.49% in Q1 2025.
- A 5-year average of 34.79% and a median of 33.34% in 2022 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2024 and 2025: FCF Margin plunged 3025 bps in 2024, then surged 1763 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 47.72% in 2022, then tumbled by 33 bps to 31.8% in 2023, then jumped by 41 bps to 44.74% in 2024, then plunged by 34 bps to 29.42% in 2025, then dropped by 19 bps to 23.76% in 2026.
- Business Quant data shows ABBV's FCF Margin at 23.76% in Q1 2026, 29.42% in Q4 2025, and 42.11% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 20.59% |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 15.19% |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 6.09% |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 23.76% |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 17.97% |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 17.14% |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 34.87% |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 93.16% |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 6.59% |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.76% |
| Dec 31, 2025 | 29.42% |
| Sep 30, 2025 | 42.11% |
| Jun 30, 2025 | 31.67% |
| Mar 31, 2025 | 10.49% |
| Dec 31, 2024 | 44.74% |
| Sep 30, 2024 | 35.95% |
| Jun 30, 2024 | 14.04% |
| Mar 31, 2024 | 31.25% |
| Dec 31, 2023 | 31.80% |
| Sep 30, 2023 | 52.81% |
| Jun 30, 2023 | 44.29% |
| Mar 31, 2023 | 32.87% |
| Dec 31, 2022 | 47.72% |
| Sep 30, 2022 | 50.13% |
| Jun 30, 2022 | 33.34% |
| Mar 31, 2022 | 35.06% |
| Dec 31, 2021 | 32.84% |
| Sep 30, 2021 | 53.81% |
| Jun 30, 2021 | 33.63% |